Manama, Dr. Ahmed Mohammed Al Ansari, Chief Executive of the National Health Regulatory Authority (NHRA), and Dr. Hisham Saad Al Jadhey, CEO of Saudi Food and Drug Authority (SFDA), signed a Memorandum of Understanding (MoU) to enhance collaboration on the approval of pharmaceuticals and medical devices between Bahrain and Saudi Arabia. The signing was attended by Lieutenant General Dr. Shaikh Mohamed bin Abdullah Al Khalifa, Chairman of the Supreme Council of Health (SCH). Dr. Al Ansari affirmed that this agreement strengthens cooperation between the two authorities, enabling Bahrain to recognise and approve pharmaceutical products and medical devices already authorised by Saudi Arabia's SFDA. He added that the MoU will allow for smoother regulatory processes by aligning standards for pharmaceuticals and medical devices approved by the SFDA, supporting the health sector in both countries. The NHRA and SFDA have signed an agreement in 2019. Source: Bahrain News Agency
Related Articles
China’s First Major Shale Oil Field Surpasses 100 Million Tons in Reserves
Muscat: Sinopec, China’s largest oil refiner, has announced the discovery of two major shale oilfields in the east of the country with combined proven reserves of 180 million tonnes, after the discovered reserves in the Xinxing shale oil field in east…
National Science, Technology, Engineering, and Mathematics Week Activities Commencement in South Al Batinah
South al batinah: The activities of the fourth edition of the National Science, Technology, Engineering, and Mathematics (STEM) Week commenced today at the General Directorate of Education in South Al Batinah Governorate. Held under the theme ‘Our Sci…
Mayon Volcano, Philippines’ Most Active Volcano, Erupts Blanketing Villages in Ash
Muscat: Mayon Volcano, the Philippines’ most active volcano, erupted today, covering surrounding villages with ash, authorities said.
According to Oman News Agency, about 52 villages in Albay province, 330 kilometres southeast of Manila, have been a…